Main Session
Sep
29
EDU 32 - ASTRO/SNO Joint Session: Current Multidisciplinary Management of Molecularly Defined IDH Mutant Grade 2 - 3 Glioma - Who, What, When, Why and How?
ASTRO/SNO Joint Session: Current Multidisciplinary Management of Molecularly Defined IDH Mutant Grade 2 - 3 Glioma - Who, What, When, Why and How?
Presenter(s)
Roshan Prabhu, MD, MS - Levine Cancer Institute, CHARLOTTE, NC